Clinical Trial Detail

NCT ID NCT01037790
Title PHASE II TRIAL OF THE CYCLIN-DEPEDENT KINASE INHIBITOR PD 0332991 IN PATIENTS WITH CANCER
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Abramson Cancer Center of the University of Pennsylvania
Indications

esophageal cancer

germ cell cancer

breast cancer

Advanced Solid Tumor

stomach cancer

colorectal cancer

Therapies

Palbociclib

Age Groups: adult senior

Additional content available in CKB BOOST